The Food and Drugs Authority (FDA) has taken a significant step towards digital transformation with the launch of its new Online Advertisement Application Portal.
The launch event was held at the T.C. Corquaye Conference Room in the FDA offices, bringing together key stakeholders, including members of the Executive Committee, management, directors, partners, and stakeholders.
The new portal is designed to revolutionize the process of submitting, reviewing, and approving advertisements for FDA-regulated products, making it more efficient and convenient.
According to the Chief Executive Officer of the FDA, Dr. Delese Darko, the platform aims to enhance convenience, transparency, and accessibility for customers.
With the new portal, customers can now submit advertisements, make payments, and receive approvals without the need for physical visits to the FDA offices.
Dr. Darko emphasized that the launch of the platform reflects the FDA’s commitment to innovation, efficiency, and customer-centricity.
The FDA’s mandate under the Public Health Act, 2012 (Act 851) includes the regulation of product advertisements, and the new portal is expected to simplify this process significantly.
The portal provides a clear and traceable record of all transactions and communications, ensuring transparency and accountability in the advertising process for all stakeholders.
The development of the portal was made possible through collaboration with Proper-Alliance, an affiliate of the AFCTA Network Hub, and other key partners, and the FDA expressed its gratitude to all those involved.
The FDA encourages all stakeholders to embrace the new platform and join in the collective effort to maintain the highest standards of product quality and safety across the country.
